Guy Aymard
Impact in
- Virology top 5%
- HIV Research and Treatment
-
- Nosocomial Infections in ICU
Papers in
-
- HIV/AIDS drug development and treatment 8
- Co-authors
- Philippe Lechat (10 shared papers)B. Diquet (5 shared papers)N. Costedoat‐Chalumeau (5 shared papers)Bertrand Diquet (12 shared papers)Jean-Marie Dangou (1 shared paper)Zahir Amoura (4 shared papers)A. Mahé (1 shared paper)Fatimata Ly (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (2 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (2 papers)The International Journal of Neuropsychopharmacology (1 paper)Journal of Pharmaceutical and Biomedical Analysis (1 paper)American Journal of Nephrology (1 paper)
- Partner nations
- FranceUnited StatesBrazil
In The Last Decade
Guy Aymard
35 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 118
- Virology 159
- Critical Care and Intensive Care Medicine 110
- Rheumatology 328
- Infectious Diseases 332
- Ophthalmology 136
Countries citing papers authored by Guy Aymard
This map shows the geographic impact of Guy Aymard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Aymard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Aymard more than expected).
Fields of papers citing papers by Guy Aymard
This network shows the impact of papers produced by Guy Aymard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Aymard. The network helps show where Guy Aymard may publish in the future.
Co-authors
The 25 scholars most cited alongside Guy Aymard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 224 | |
| 2 | 2003 | 182 | |
| 3 | 2000 | 160 | |
| 4 | 2011 | 151 | |
| 5 | 2007 | 140 | |
| 6 | 2002 | 90 | |
| 7 | 2000 | 82 | |
| 8 | 1997 | 79 | |
| 9 | 2003 | 68 | |
| 10 | 2003 | 42 | |
| 11 | 2000 | 36 | |
| 12 | 2008 | 34 | |
| 13 | 2000 | 34 | |
| 14 | 2001 | 30 | |
| 15 | 2006 | 26 | |
| 16 | 2001 | 23 | |
| 17 | 2006 | 22 | |
| 18 | 2003 | 21 | |
| 19 | 2001 | 15 | |
| 20 | 2010 | 15 |
About Guy Aymard
Guy Aymard is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Virology and Rheumatology, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (4 papers), Pharmacology and Obesity Treatment (3 papers), Systemic Lupus Erythematosus Research (3 papers), Pharmacological Effects and Assays (2 papers), Metabolism and Genetic Disorders (2 papers), Pain Mechanisms and Treatments (2 papers) and Anesthesia and Sedative Agents (2 papers). The work is most often cited by research in Virology (159 citations), Critical Care and Intensive Care Medicine (110 citations), Rheumatology (328 citations), Infectious Diseases (332 citations) and Ophthalmology (136 citations). Guy Aymard has collaborated with scholars based in France, United States and Brazil. Frequent co-authors include Philippe Lechat, B. Diquet, N. Costedoat‐Chalumeau, Bertrand Diquet, Jean-Marie Dangou, Zahir Amoura, A. Mahé, Fatimata Ly, Jean‐Sébastien Hulot and B. Wechsler. Their work appears in journals such as British Journal of Clinical Pharmacology, JAIDS Journal of Acquired Immune Deficiency Syndromes, The International Journal of Neuropsychopharmacology, Journal of Pharmaceutical and Biomedical Analysis and American Journal of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.